{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-05",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "59762-2350",
      "generic_name": "Ethosuximide",
      "labeler_name": "Mylan Pharmaceuticals Inc.",
      "brand_name": "Ethosuximide",
      "active_ingredients": [
        {
          "name": "ETHOSUXIMIDE",
          "strength": "250 mg/5mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "59762-2350-6",
          "description": "1 BOTTLE, PLASTIC in 1 CARTON (59762-2350-6)  / 474 mL in 1 BOTTLE, PLASTIC",
          "marketing_start_date": "20200221",
          "sample": false
        },
        {
          "package_ndc": "59762-2350-7",
          "description": "1 BOTTLE, PLASTIC in 1 CARTON (59762-2350-7)  / 474 mL in 1 BOTTLE, PLASTIC",
          "marketing_start_date": "20220701",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Mylan Pharmaceuticals Inc."
        ],
        "rxcui": [
          "251322"
        ],
        "spl_set_id": [
          "19c924c2-f558-4c78-9277-2d7e0df2f505"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000175753",
          "N0000008486"
        ],
        "pharm_class_epc": [
          "Anti-epileptic Agent [EPC]"
        ],
        "pharm_class_pe": [
          "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
        ],
        "unii": [
          "5SEH9X1D1D"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "SOLUTION",
      "spl_id": "04f63742-92af-4b78-a7a6-f9f2f1c269e7",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20200221",
      "product_id": "59762-2350_04f63742-92af-4b78-a7a6-f9f2f1c269e7",
      "application_number": "ANDA080258",
      "brand_name_base": "Ethosuximide",
      "pharm_class": [
        "Anti-epileptic Agent [EPC]",
        "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
      ]
    }
  ]
}